Mycenax Biotech Market Cap

Mycenax Biotech has a market cap or net worth of 6.38 billion as of April 24, 2025. Its market cap has decreased by -16.77% in one year.

Market Cap

6.38B

Enterprise Value

6.98B

Revenue

683.92M

Ranking

n/a

PE Ratio

n/a

Stock Price

30.55

Market Cap Chart

Since October 31, 2008, Mycenax Biotech's market cap has increased from 584.10M to 6.38B, an increase of 991.56%. That is a compound annual growth rate of 15.60%.

Market Cap History

Date	Market Cap	% Change
Apr 23, 2025	6.38B	-28.90%
Dec 31, 2024	8.97B	22.00%
Dec 29, 2023	7.35B	-4.53%
Dec 30, 2022	7.70B	32.48%
Dec 30, 2021	5.81B	40.74%
Dec 31, 2020	4.13B	38.50%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	160.86B
Caliway Biopharmaceuticals	93.07B
Bora Pharmaceuticals Co., LTD.	67.36B
Lotus Pharmaceutical	54.79B
Polaris Group	30.00B
Oneness Biotech	28.11B
Pegavision	25.35B
Lumosa Therapeutics	24.91B

Market Cap Rankings